| Date Filed | Type | Description |
| 08/15/2023 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1579, valued at
$171.5k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Phreesia, Inc.|
Txns:
| Granted 6,051 shares
@ $0 |
|
| 05/26/2023 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Granted 9,834 restricted stock units
@ $0 |
|
| 04/05/2023 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Phreesia, Inc.|
Txns:
| Sold 6,500 shares
@ $30.6895, valued at
$199.5k
Sold 500 shares
@ $31.771, valued at
$15.9k
Exercised 7,000 options
@ $4.71, valued at
$33k
|
|
| 04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 12/06/2022 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 420 shares
@ $154.6806, valued at
$65k
|
|
| 08/09/2022 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,561 shares
@ $0
Sold 1,089 shares
@ $152.3225, valued at
$165.9k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2021 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Phreesia, Inc.|
Txns:
| Granted 2,605 shares
@ $0 |
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,590 shares
@ $0
Granted 6,475 options to buy
@ $170.74, valued at
$1.1M
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
3
| Smith Mark Douglas (Director) has filed a Form 3 on Jazz Pharmaceuticals plc |
| 08/12/2020 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Phreesia, Inc.|
Txns:
| Sold 6,000 shares
@ $30.3041, valued at
$181.8k
Exercised 6,000 options to buy
@ $4.71, valued at
$28.3k
|
|
| 07/21/2020 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Phreesia, Inc.|
Txns:
| Granted 6,110 shares
@ $0 |
|
| 06/01/2020 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Exercised 3,012 restricted stock units
@ $0
Granted 1,049 restricted stock units
@ $0 |
|
| 07/17/2019 |
3
| Smith Mark Douglas (Director) has filed a Form 3 on Phreesia, Inc. |
| 06/03/2019 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Granted 3,012 restricted stock units
@ $0 |
|
| 10/22/2018 |
3
| Smith Mark Douglas (Director) has filed a Form 3 on Teladoc Health, Inc. |